“I saw a burst of color ... to enter the new field of gene therapy. Working together, the pair showed they could improve the vision of mice born with genetic blindness. In 2000, they tested ...

Bottom Line: An innovative gene therapy treatment restored vision in adults with a rare form of congenital blindness. Researchers at the University of Pennsylvania announced in April 2008 the use ...

Our contribution to this research drive involves developing a new type of gene therapy to reprogramme cells deep in the eye to sense light. The ultimate aim is to treat all types of blindness caused ...

Four children born with a rare genetic form of severe blindness have all experienced significant improvements in their eyesight after being treated with an experimental new gene therapy.

Gyroscope Therapeutics and its gene therapy for the sight-robbing disease ... innovation in ophthalmology to treat and prevent blindness worldwide," she added. Gyroscope is one of the portfolio ...

Atsena Therapeutics has raised $150 million in a round led by Bain Capital, a private investment firm based in Boston. The ...

On the heels of its acquisition by Ocuphire Pharma, Opus is planning next steps for its Leber congenital amaurosis type 5 ...

Stock image of an optometrist's eye chart. After the trial gene therapy, four children with LCA-AIPL1 who were born blind became able to make out the top letter on such a chart. Stock image of an ...

Zandy Forbes’ biotech company MeiraGTx has developed targeted gene therapy methods to treat more than just genetic disorders. Now it’s on the cusp of its first regulatory approval.

The first NHS patients have started treatment with Novartis’ Luxturna, a gene therapy for a sight-robbing ... childhood and he is now registered as blind. “After participating in 15 years ...

Scientists have restored vision and hearing in people born with congenital blindness or deafness in two separate gene therapy trials A British toddler born deaf has become the first person to have ...